Steven Quinn, MD
Critical Care Medicine · Palos Park, ILNPI 1730446998
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Intuitive Surgical at 47.0% of the total. 2025 is the largest year on record at $9,134, more than ten times the $749 reported in 2019. Among critical care medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 391 payments — averaging $39.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- GSK$2K
- AstraZeneca$1K
- Pulmonx Corporation$514
- Boehringer Ingelheim$512
- Amgen$387
- plus $3K from 31 others
What the payments were for
- Travel & lodging$1,1748%
- Food & beverage$8,12353%
- Education$6,05839%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $7,223 |
| GSK | 138 | $1,988 |
| AstraZeneca | 59 | $1,359 |
| Pulmonx Corporation | 6 | $514 |
| Boehringer Ingelheim | 22 | $512 |
| Amgen | 12 | $387 |
| Sanofi | 14 | $320 |
| Electromed, Inc. | 23 | $310 |
| Grifols USA, LLC | 12 | $266 |
| Regeneron Healthcare Solutions, Inc. | 7 | $227 |
| Actelion Pharmaceuticals US, Inc. | 10 | $227 |
| Jazz Pharmaceuticals Inc. | 6 | $221 |
| Insmed, Inc. | 10 | $216 |
| Philips North America LLC | 6 | $181 |
| AbbVie | 7 | $155 |
| Mylan Specialty L.p. | 8 | $149 |
| Genentech USA, Inc. | 7 | $133 |
| Medical Device Business Services, Inc. | 1 | $125 |
| Organogenesis Inc. | 1 | $118 |
| United Therapeutics Corporation | 4 | $116 |
| Merck | 3 | $61 |
| Ceribell, Inc. | 1 | $60 |
| ANI Pharmaceuticals, Inc. | 2 | $54 |
| Baxter Healthcare | 2 | $50 |
| Sunovion Pharmaceuticals Inc. | 4 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Johnson & Johnson | 2 | $41 |
| Harmony Biosciences LLC | 1 | $40 |
| Viatris Specialty LLC | 2 | $37 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $27 |
| Novartis | 1 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $24 |
| Verona Pharma, Inc. | 1 | $24 |
| La Jolla Pharmaceutical Company | 1 | $18 |
| Vapotherm Inc | 1 | $17 |
| Circassia Inc. | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,058
- CHARTIS CATHETER$434
- ZEPHYR DELIVERY CATHETER$434
- ZEPHYR ENDOBRONCHIAL VALVE$434
- PULMONX CHARTIS TABLET CONSOLE$434
- FASENRA$125
- NA$125
- NUCALA$123
- TEZSPIRE$121
- PuraPly$118
How this compares
$15,355 in reported general payments places this provider in the 95th percentile of 281 critical care medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 144 | $139,105 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 11 | $81,163 |
| Fasenra PenBenralizumab | 11 | $59,848 |
| Breo ElliptaFluticasone/Vilanterol | 65 | $44,742 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 37 | $21,250 |
| Spiriva RespimatTiotropium Bromide | 20 | $20,461 |
| Incruse ElliptaUmeclidinium Bromide | 51 | $17,831 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $15,484 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $4,901 |
| Arnuity ElliptaFluticasone Furoate | 14 | $4,449 |
| Advair HfaFluticasone Propion/Salmeterol | 14 | $3,662 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 81 | $2,555 |
| Ventolin HfaAlbuterol Sulfate | 20 | $2,279 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,606 |
| Zafirlukast | 11 | $1,009 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Anoro Ellipta, Arnuity Ellipta | $1,988 | $221,611292 claims |
| Grifols USA, LLCProlastin C | $266 | $81,16311 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $512 | $41,71157 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 281 critical care medicine providers in Illinois.
Other critical care medicine in Palos Park
- Husam NayefPalos Park$24K
- Sarah UsmaniPalos Park$7K
- Tabassum HanifPalos Park$6K
- Rafat MohammedPalos Park$5K
- Julia EspelPalos Park$5K
- Rohinee BeriPalos Park$4K
- Brian ReichardtO Fallon$892K
- Michael CutticaChicago$402K
- Daniel DillingMaywood$208K
- Israel RubinsteinChicago$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.